Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Globalization and Health
Published in: Globalization and Health 1/2020

Open Access 01-12-2020 | Tuberculosis | Review

Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria

Authors: Jillian Clare Kohler, Andrea Bowra

Published in: Globalization and Health | Issue 1/2020

Login to get access

Abstract

Corruption is recognized by the global community as a threat to development generally and to achieving health goals, such as the United Nations Sustainable Development Goal # 3: ensuring healthy lives and promoting well-being for all. As such, international organizations such as the World Health Organizations and the United Nations Development Program are creating an evidence base on how best to address corruption in health systems. At present, the risk of corruption is even more apparent, given the need for quick and nimble responses to the COVID-19 pandemic, which may include a relaxation of standards and the rapid mobilization of large funds. As international organizations and governments attempt to respond to the ever-changing demands of this pandemic, there is a need to acknowledge and address the increased opportunity for corruption.
In order to explore how such risks of corruption are addressed in international organizations, this paper focuses on the question: How are international organizations implementing measures to promote accountability and transparency, and anti-corruption, in their own operations? The following international organizations were selected as the focus of this paper given their current involvement in anti-corruption, transparency, and accountability in the health sector: the World Health Organization, the United Nations Development Program, the World Bank Group, and the Global Fund to Fight Aids, Tuberculosis and Malaria. Our findings demonstrate that there has been a clear increase in the volume and scope of anti-corruption, accountability, and transparency measures implemented by these international organizations in recent years. However, the efficacy of these measures remains unclear. Further research is needed to determine how these measures are achieving their transparency, accountability, and anti-corruption goals.
Literature
1.
2.
3.
4.
Mauro P, Medas P, Fournier J-M. The cost of corruption. Finance Dev. 2019;56(3):26–9.
5.
Kreuter MW, De Rosa C, Howze EH, Baldwin GT. Understanding wicked problems: a key to advancing environmental health promotion. Health Educ Behav. 2004;31(4):441–54.PubMed
6.
Glynn P, Kobrin SJ, Naim M. The globalization of corruption. Corrupt Glob Econ. 1997;7:17.
7.
Hiatt F. Corruption is finally getting the attention it needs. International Herald Tribune. 1999;25.
8.
9.
Mackey TK. Opening the policy window to mobilize action against corruption in the health sector: comment on “we need to talk about corruption in health systems”. Int J Health Policy Manag. 2019;8(11):668.PubMedPubMedCentral
10.
11.
12.
13.
Kohler JC. I know it when I see it: the challenges of addressing corruption in health systems: comment on “we need to talk about corruption in health systems”. Int J Health Policy Manag. 2019;8(9):563.PubMedPubMedCentral
14.
Kohler JC, Dimancesco D. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk. Glob Health Action. 2020;13(sup1):1694745.PubMedPubMedCentral
15.
16.
Kamerow D. Covid-19: the crisis of personal protective equipment in the US. BMJ. 2020;369:m1367.PubMed
17.
Gomez LDT. COVID-19: analysis of corruption in public procurement 2020; 2020.
18.
19.
20.
21.
Kohler JC, Mackey TK, Ovtcharenko N. Why the MDGs need good governance in pharmaceutical systems to promote global health. BMC Public Health. 2014;14(1):1–8.
22.
Brinkerhoff DW. Accountability and health systems: toward conceptual clarity and policy relevance. Health Policy Plan. 2004;19(6):371–9.PubMed
23.
24.
Organisation for Economic Co-Operation and Development. Putting an end to corruption. 2016.
25.
Hapuhennedige S, Bernsen EC, Kohler JC. Exploring accountability and transparency within international organizations: what do we know and what do we need to know? In: Cahyurt KT, editor. Integrity, transparency and corruption in healthcare & research on health; 2020. p. 125–39.
26.
Handl G. The legal mandate of multilateral development banks as agents for change toward sustainable development. Am J Int’l Law. 1998;92(4):642–65.
27.
Kapur D. Expansive agendas and weak instruments: governance related conditionalities of international financial institutions. J Policy Reform. 2001;4(3):207–41.
28.
Thomas C. Does the good governance policy of the international financial institutions privilege markets at the expense of democracy. Conn J Int’l L. 1999;14:551.
29.
Lewis M. Governance and corruption in public health care systems. Center for Global Development working paper. 2006(78).
30.
Savedoff WD, Hussmann K. Why are health systems prone to corruption. Global Corruption Report. 2006;2006:4–16.
31.
Gurkan A. Demand for good governance in the World Bank: conceptual evolution, frameworks and activities. Washington DC: World Bank Group; 2010.
32.
Vian T, Kohler JC. Medicines Transparency Alliance (MeTA): pathways to transparency, accountability and access. Geneva: World Health Organization; 2016.
33.
Brinkerhoff DW. Accountability and health systems: overview, framework, and strategies; 2003.
34.
Scott C. Figuring out accountability: selected uses of official statistics by civil society to improve public sector performance. Toronto: Centre for International Studies; 2007.
35.
United Nations Economic and Social Commission for Asia and the Pacific. What is good governance? 2008.
36.
37.
38.
39.
40.
United Nations Development Programme. Investigations guidelines. 2019.
41.
42.
43.
44.
45.
46.
47.
United Nations Development Programme. Internal audit reports issued since 1 December 2012. 2012.
48.
49.
50.
United Nations Development Programme tEO. The ethics office. 2018.
51.
United Nations Development Programme tEO. Policy for protection against retaliation: for reporting misconduct or cooperating with a duly authorized audit or investigation. 2018.
52.
53.
54.
55.
56.
57.
United Nations Development Programme OoAaI. 2015 UNDP annual report of the administrator on disciplinary measures and other actions taken in response to fraud, corruption, and other wrongdoing. 2016.
58.
59.
United Nations Development Programme. Financial report and audited financial statements for the biennium ended 31 December 2009 and report of the Board of Auditors. 2010.
60.
United Nations Development Programme. Financial report and audited financial statements for the biennium ended 31 December 2007 and report of the Board of Auditors. 2008.
61.
United Nations Development Programme. Financial report and audited financial statements for the biennium ended 31 December 2018 and report of the Board of Auditors. 2019.
62.
63.
64.
65.
66.
The Global Fund Office of the Inspector General. The Office of the Inspector General 2018 annual report. 2019.
67.
The Global Fund Office of the Inspector General. Proactive investigation of procurements of non-compliant HIV rapid diagnostic testing kits. 2018.
68.
69.
The Global Fund. 40th board meeting: joint Agreed Management Actions (AMAs) progress report. 2018.
70.
Usher AD. Global Fund plays hard ball on corruption. Lancet. 2016;397(10015):213–4.CrossRef
71.
72.
73.
The World Bank Group Sanctions Board. Sanctions Board decision no. 121 (sanctions case no. 555). 2019.
74.
The World Bank Group. World Bank Group sanctions system annual report. 2019.
75.
76.
Gilbert DU, Rasche A, Waddock S. Accountability in a global economy: the emergence of international accountability standards. Bus Ethics Q. 2011;21(1):23–44.CrossRef
77.
Rose-Ackerman S, Kalifka BJ. Corruption and government: causes, consequences, and reform. 2nd ed. Cambridge: Cambridge University Press; 2016.CrossRef
78.
Deshman AC. Horizonal review between international organizations: why, how, and who cares about corporate regulatory capture. Eur J Int Law. 2011;22(4):1089–113.CrossRef
79.
Bauhr M, Nasiritousi N. How do international organizations promote quality of government? Contestation, integration, and the limits of IO power. Int Stud Rev. 2012;14(4):541–66.CrossRef
80.
Coicaud JM. Evaluation, international organizations, and global policy: an introduction. Glob Policy. 2016;7(3):420–5.
81.
Berkman S, et al. The fight against corruption: international organizations at a cross-roads. J Financ Crime. 2008;15(2):124–54.
82.
Grigorescu A. International organizations and government transparency: linking the international and domestic realms. Int Stud Q. 2003;47(4):643–67.
83.
Fourie AN. Expounding the place of legal doctrinal methods in legal-interdisciplinary research. Erasmus Law Rev. 2015;8:95.
Metadata
Title
Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Authors
Jillian Clare Kohler
Andrea Bowra
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2020
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-020-00629-5

Other articles of this Issue 1/2020

Globalization and Health 1/2020 Go to the issue

Commentary

Assessing COVID-19 through the lens of health systems’ preparedness: time for a change

Research

Bibliometric analysis of peer-reviewed literature on climate change and human health with an emphasis on infectious diseases

Research

Systematic review of early abortion services in low- and middle-income country primary care: potential for reverse innovation and application in the UK context

Research

Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis

Research

Incorporating operational research in programmes funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria in four sub-Saharan African countries

Research

A survey of retail prices of antimicrobial products used in small-scale chicken farms in the Mekong Delta of Vietnam